Overview
The Ministry of Health and Family Welfare (MoHFW) inaugurated a free, single‑dose Gardasil‑4 vaccination drive for all 14‑year‑old girls across India on 28 February 2026. The programme integrates recent health‑research regulatory reforms to ensure ethical conduct and safety monitoring.
Key Developments
- Implementation of the NDCTR 2019, mandating registration of ethics committees with the DHR and prospective trial registration on the CTRI.
- Strengthened ethical review mechanisms, with updated ICMR National Ethical Guidelines (2017) emphasizing scientific validity, risk minimisation, and participant follow‑up.
- Mandatory parental consent and voluntary participation; beneficiaries register via the U‑WIN digital platform.
- Vaccines administered at government health facilities (PHCs, CHCs, SDHs/DHs, GMCs) under medical officer supervision, linked to 24×7 AEFI Management Centres for rapid response.
- Extensive training of medical and paramedical staff across all 36 States/UTs, guided by recommendations of the NTAGI, WHO, and SAGE.
Important Facts
• Target group: Girls aged 14 years.
• Vaccine: Single‑dose Gardasil‑4, provided free of cost.
• Delivery points: Ayushman Arogya Mandirs, Primary Health Centres, Community Health Centres, Sub‑District/District Hospitals, and Government Medical Colleges.
• Consent: Mandatory parental consent; registration on U‑WIN.
• Safety: 24‑hour AEFI monitoring centres; medical officers trained for adverse‑event management.
Exam Relevance
Understanding this programme helps aspirants in GS 2 (Health Governance) and GS 3 (Public Health). It illustrates how policy formulation, regulatory reforms (NDCTR, ethics‑committee registration), and inter‑agency coordination (MoHFW, DHR, CDSCO, ICMR, NTAGI) translate into a large‑scale public‑health intervention. The emphasis on ethical oversight and AEFI monitoring aligns with the broader theme of safeguarding vulnerable populations, a frequent UPSC essay topic.
Way Forward
• Strengthen real‑time AEFI data analytics to further improve vaccine confidence.
• Expand the programme to include catch‑up vaccination for older cohorts.
• Periodic review of ethical guidelines to incorporate emerging technologies in vaccine research.
• Enhance inter‑state monitoring mechanisms to ensure uniform implementation across diverse regions.